Background Multiple sclerosis is an inflammatory disease ofthe central nervous system that destroys myelin, oligodendrocytes,and axons. Since most of the lesions of multiple sclerosis arenot remyelinated, enhancement of remyelination is a possibletherapeutic strategy that could perhaps be achieved with thetransplantation of oligodendrocyte-producing cells into thelesions. We investigated the frequency distribution and configurationof oligodendrocytes in chronic lesions of multiple sclerosisto determine whether these factors limit remyelination.
Methods Forty-eight chronic lesions obtained at autopsy from10 patients with multiple sclerosis were examined immunocytochemicallyfor oligodendrocytes and oligodendrocyte progenitor cells. Usingconfocal microscopy, we examined the three-dimensional relationsbetween axons and the processes of premyelinating oligodendrocytes.
Results Thirty-four of the 48 chronic lesions of multiple sclerosiscontained oligodendrocytes with multiple extended processesthat associated with demyelinated axons but failed to myelinatethem. These axons were dystrophic and contained multiple swellings.In some regions, the densities of premyelinating oligodendrocytes(25 per square millimeter of tissue) were similar to those inthe developing rodent brain (23 per square millimeter). In thepatients with disease of long duration (more than 20 years),there were fewer lesions with premyelinating oligodendrocytes(P<0.001).
Conclusions Premyelinating oligodendrocytes are present in chroniclesions of multiple sclerosis, so remyelination is not limitedby an absence of oligodendrocyte progenitors or their failureto generate oligodendrocytes. Our findings suggest that in thechronic lesions of multiple sclerosis, the axons are not receptivefor remyelination. Understanding the cellular interactions betweenpremyelinating oligodendrocytes, axons, and the microenvironmentof lesions of multiple sclerosis may lead to effective strategiesfor enhancing remyelination.
Source Information
From the Department of Neurosciences, Lerner Research Institute (A.C., B.D.T.), and the Mellen Center for Multiple Sclerosis (R.R.), Cleveland Clinic Foundation, Cleveland; and the Department of Neurology, West Los Angeles Veterans Affairs Medical Center, Los Angeles (W.W.T.).
Address reprint requests to Dr. Trapp at the Department of Neurosciences, NC30, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195, or at trappb{at}ccf.org.
Buckley, C. E., Goldsmith, P., Franklin, R. J. M.
(2008). Zebrafish myelination: a transparent model for remyelination?. DMM
1: 221-228
[Abstract][Full Text]
Zivadinov, R., Reder, A. T., Filippi, M., Minagar, A., Stuve, O., Lassmann, H., Racke, M. K., Dwyer, M. G., Frohman, E. M., Khan, O.
(2008). Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology
71: 136-144
[Abstract][Full Text]
Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., Bruck, W.
(2008). Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain
131: 1749-1758
[Abstract][Full Text]
Cheng, X., Wang, Y., He, Q., Qiu, M., Whittemore, S. R., Cao, Q.
(2007). Bone Morphogenetic Protein Signaling and Olig1/2 Interact to Regulate the Differentiation and Maturation of Adult Oligodendrocyte Precursor Cells. Stem Cells
25: 3204-3214
[Abstract][Full Text]
Williams, A., Piaton, G., Aigrot, M.-S., Belhadi, A., Theaudin, M., Petermann, F., Thomas, J.-L., Zalc, B., Lubetzki, C.
(2007). Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?. Brain
130: 2554-2565
[Abstract][Full Text]
Herrero-Herranz, E., Pardo, L. A., Bunt, G., Gold, R., Stuhmer, W., Linker, R. A.
(2007). Re-Expression of a Developmentally Restricted Potassium Channel in Autoimmune Demyelination: Kv1.4 Is Implicated in Oligodendroglial Proliferation. Am. J. Pathol.
171: 589-598
[Abstract][Full Text]
Lisak, R. P.
(2007). Neurodegeneration in multiple sclerosis: Defining the problem. Neurology
68: S5-S12
[Abstract][Full Text]
Liu, J.-Q., Carl, J. W. Jr, Joshi, P. S., RayChaudhury, A., Pu, X.-A., Shi, F.-D., Bai, X.-F.
(2007). CD24 on the Resident Cells of the Central Nervous System Enhances Experimental Autoimmune Encephalomyelitis. J. Immunol.
178: 6227-6235
[Abstract][Full Text]
Novgorodov, A. S., El-Alwani, M., Bielawski, J., Obeid, L. M., Gudz, T. I.
(2007). Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J.
21: 1503-1514
[Abstract][Full Text]
Nait-Oumesmar, B., Picard-Riera, N., Kerninon, C., Decker, L., Seilhean, D., Hoglinger, G. U., Hirsch, E. C., Reynolds, R., Baron-Van Evercooren, A.
(2007). Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitors. Proc. Natl. Acad. Sci. USA
104: 4694-4699
[Abstract][Full Text]
Benito, C., Romero, J. P., Tolon, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C., Romero, J.
(2007). Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis. J. Neurosci.
27: 2396-2402
[Abstract][Full Text]
Nishiyama, A.
(2007). Polydendrocytes: NG2 Cells with Many Roles in Development and Repair of the CNS. Neuroscientist
13: 62-76
[Abstract]
Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., Bruck, W., Lucchinetti, C., Lassmann, H.
(2006). Remyelination is extensive in a subset of multiple sclerosis patients. Brain
129: 3165-3172
[Abstract][Full Text]
Zhang, Y., Taveggia, C., Melendez-Vasquez, C., Einheber, S., Raine, C. S., Salzer, J. L., Brosnan, C. F., John, G. R.
(2006). Interleukin-11 Potentiates Oligodendrocyte Survival and Maturation, and Myelin Formation.. J. Neurosci.
26: 12174-12185
[Abstract][Full Text]
Gao, L., Miller, R. H.
(2006). Specification of optic nerve oligodendrocyte precursors by retinal ganglion cell axons.. J. Neurosci.
26: 7619-7628
[Abstract][Full Text]
Kotter, M. R., Li, W.-W., Zhao, C., Franklin, R. J. M.
(2006). Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation. J. Neurosci.
26: 328-332
[Abstract][Full Text]
Mahad, D., Callahan, M. K., Williams, K. A., Ubogu, E. E., Kivisakk, P., Tucky, B., Kidd, G., Kingsbury, G. A., Chang, A., Fox, R. J., Mack, M., Sniderman, M. B., Ravid, R., Staugaitis, S. M., Stins, M. F., Ransohoff, R. M.
(2006). Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. Brain
129: 212-223
[Abstract][Full Text]
Foote, A. K., Blakemore, W. F.
(2005). Inflammation stimulates remyelination in areas of chronic demyelination. Brain
128: 528-539
[Abstract][Full Text]
Xin, M., Yue, T., Ma, Z., Wu, F.-f., Gow, A., Lu, Q. R.
(2005). Myelinogenesis and Axonal Recognition by Oligodendrocytes in Brain Are Uncoupled in Olig1-Null Mice. J. Neurosci.
25: 1354-1365
[Abstract][Full Text]
Jaillard, C., Harrison, S., Stankoff, B., Aigrot, M. S., Calver, A. R., Duddy, G., Walsh, F. S., Pangalos, M. N., Arimura, N., Kaibuchi, K., Zalc, B., Lubetzki, C.
(2005). Edg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival. J. Neurosci.
25: 1459-1469
[Abstract][Full Text]
Arnett, H. A., Fancy, S. P. J., Alberta, J. A., Zhao, C., Plant, S. R., Kaing, S., Raine, C. S., Rowitch, D. H., Franklin, R. J. M., Stiles, C. D.
(2004). bHLH Transcription Factor Olig1 Is Required to Repair Demyelinated Lesions in the CNS. Science
306: 2111-2115
[Abstract][Full Text]
Ruffini, F., Arbour, N., Blain, M., Olivier, A., Antel, J. P.
(2004). Distinctive Properties of Human Adult Brain-Derived Myelin Progenitor Cells. Am. J. Pathol.
165: 2167-2175
[Abstract][Full Text]
Wosik, K., Ruffini, F., Almazan, G., Olivier, A., Nalbantoglu, J., Antel, J. P.
(2004). Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury. Brain
127: 2636-2648
[Abstract][Full Text]
Fernandez, M., Giuliani, A., Pirondi, S., D'Intino, G., Giardino, L., Aloe, L., Levi-Montalcini, R., Calza, L.
(2004). Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc. Natl. Acad. Sci. USA
101: 16363-16368
[Abstract][Full Text]
Colognato, H., Ramachandrappa, S., Olsen, I. M., ffrench-Constant, C.
(2004). Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. JCB
167: 365-375
[Abstract][Full Text]
Stidworthy, M. F., Genoud, S., Li, W.-W., Leone, D. P., Mantei, N., Suter, U., Franklin, R. J. M.
(2004). Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain
127: 1928-1941
[Abstract][Full Text]
Dietrich, J., Blumberg, B. M., Roshal, M., Baker, J. V., Hurley, S. D., Mayer-Proschel, M., Mock, D. J.
(2004). Infection with an Endemic Human Herpesvirus Disrupts Critical Glial Precursor Cell Properties. J. Neurosci.
24: 4875-4883
[Abstract][Full Text]
Ruffini, F., Kennedy, T. E., Antel, J. P.
(2004). Inflammation and Remyelination in the Central Nervous System: A Tale of Two Systems. Am. J. Pathol.
164: 1519-1522
[Full Text]
Mason, J. L., Toews, A., Hostettler, J. D., Morell, P., Suzuki, K., Goldman, J. E., Matsushima, G. K.
(2004). Oligodendrocytes and Progenitors Become Progressively Depleted within Chronically Demyelinated Lesions. Am. J. Pathol.
164: 1673-1682
[Abstract][Full Text]
Jarjour, A. A., Kennedy, T. E.
(2004). Oligodendrocyte Precursors on the Move: Mechanisms Directing Migration. Neuroscientist
10: 99-105
[Abstract]
Levin, L. A., Ritch, R., Richards, J. E., Borras, T.
(2004). Stem Cell Therapy for Ocular Disorders. Arch Ophthalmol
122: 621-627
[Abstract][Full Text]
Giraudon, P., Vincent, P., Vuaillat, C., Verlaeten, O., Cartier, L., Marie-Cardine, A., Mutin, M., Bensussan, A., Belin, M.-F., Boumsell, L.
(2004). Semaphorin CD100 from Activated T Lymphocytes Induces Process Extension Collapse in Oligodendrocytes and Death of Immature Neural Cells. J. Immunol.
172: 1246-1255
[Abstract][Full Text]
Larsen, P. H., Wells, J. E., Stallcup, W. B., Opdenakker, G., Yong, V. W.
(2003). Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan. J. Neurosci.
23: 11127-11135
[Abstract][Full Text]
Mason, J. L., Xuan, S., Dragatsis, I., Efstratiadis, A., Goldman, J. E.
(2003). Insulin-Like Growth Factor (IGF) Signaling through Type 1 IGF Receptor Plays an Important Role in Remyelination. J. Neurosci.
23: 7710-7718
[Abstract][Full Text]
Imitola, J., Snyder, E. Y., Khoury, S. J.
(2003). Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis. Physiol. Genomics
14: 171-197
[Abstract][Full Text]
Bo, L, Vedeler, C A, Nyland, H, Trapp, B D, Mork, S J
(2003). Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler
9: 323-331
[Abstract]
Barkhof, F., Bruck, W., De Groot, C. J. A., Bergers, E., Hulshof, S., Geurts, J., Polman, C. H., van der Valk, P.
(2003). Remyelinated Lesions in Multiple Sclerosis: Magnetic Resonance Image Appearance. Arch Neurol
60: 1073-1081
[Abstract][Full Text]
Penderis, J., Shields, S. A., Franklin, R. J. M.
(2003). Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain
126: 1382-1391
[Abstract][Full Text]
Armstrong, R. C., Le, T. Q., Frost, E. E., Borke, R. C., Vana, A. C.
(2002). Absence of Fibroblast Growth Factor 2 Promotes Oligodendroglial Repopulation of Demyelinated White Matter. J. Neurosci.
22: 8574-8585
[Abstract][Full Text]
Chari, D M, Blakemore, W F
(2002). New insights into remyelination failure in multiple sclerosis: implications for glial cell transplantation. Mult Scler
8: 271-277
[Abstract]
Paty, D. W., Arnold, D. L.
(2002). The Lesions of Multiple Sclerosis. NEJM
346: 199-200
[Full Text]